Insight into specific pro-arrhythmic triggers in Brugada and early repolarization syndromes: results of long-term follow-up.
Insight into specific pro-arrhythmic triggers in Brugada and early repolarization syndromes: results of long-term follow-up.
复制标题
深入了解 Brugada 和早期复极综合征的特定促心律失常触发因素:长期随访结果。
DOI:
10.1007/s00380-016-0828-8
复制
发表时间:
2016
期刊:
影响因子:
1.5
通讯作者:
Hasebe N.
中科院分区:
文献类型:
--
作者:
Talib AK;Sato N;Myojo T;Sugiyama E;Nakagawa N;Sakamoto N;Tanabe Y;Fujino T;Takeuchi T;Akasaka K;Matsuhashi H;Saijo Y;Kawamura Y;Doi A;Hasebe N.
The pro-arrhythmic triggers in Brugada and early repolarization syndromes (BrS, ERS) have not been analyzed systematically except for case reports. We clinically investigated the circumstances which precede/predispose to arrhythmic events in these syndromes during long-term follow-up. A detailed history from the patients/witnesses was taken to investigate the antecedent events in the last few hours that preceded syncope/ventricular fibrillation (VF); medical records, ECG and blood test from the emergency room (ER) were reviewed. 19 patients that fulfilled the investigation criteria were followed up for 71 ± 49 months (34–190 months). Prior to the event (syncope/VF), the patients were partaking different activities in the following decreasing order; drinking alcoholic beverage, having meal, and getting up from sleep, exercise. 3 patients reported mental/physical stress prior to the event and 2 patients developed VF several days after starting oral steroid for treatment of bronchial asthma. In the ER, elevated J-wave amplitude (0.27 ± 0.15 mV) was found with 58 % of the patients having hypokalemia. After electrolyte correction and cessation of steroids, the following day plasma K+(4.2 ± 0.3 mEq/L,P< 0.001) was significantly increased and J-wave amplitude (0.13 ± 0.1 mV,P< 0.001) was remarkably reduced. Three patients were kept on oral spironolactone/potassium supplements. During follow-up for 71 ± 49 (34–190) months, among 4 patients with VF recurrence, one patient developed VF after taking oral steroid. In ERS and BrS, hypokalemia and corticosteroid therapy add substantial pro-arrhythmic effects, but potentially treatable. Stopping steroid therapy and avoiding hypokalemia had excellent long-term outcome.